Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 214  

    Article Cited by others


Clinical Effectiveness of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Management of Renal Cell Carcinoma: A Single Institution Experience

Win Aung Zaw, Aparici Carina Mari

Year : 2015| Volume: 14| Issue : 1 | Page no: 36-40

   This article has been cited by
1 Pulmonary recurrence of renal cell carcinoma 18?years following curative surgery
Benjamin Nguyen,Indika Liyanage,Christopher Chow,Graeme Thompson
Internal Medicine Journal. 2021; 51(2): 299
[Pubmed]  [Google Scholar] [DOI]
2 Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma
Guozhu Hou,Dachun Zhao,Yuanyuan Jiang,Zhaohui Zhu,Li Huo,Fang Li,Wuying Cheng
Cancer Imaging. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
3 Role of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma
Rahul Jena,TusharAditya Narain,UdayPratap Singh,Aneesh Srivastava
Indian Journal of Urology. 2021; 37(2): 125
[Pubmed]  [Google Scholar] [DOI]
4 18F-FDG positron emission tomography combined with computed tomography in renal cell carcinoma diagnostics
V. S. Ilyakov,Artem Pronin,A. I. Mikhaylov,A. V. Parnas,Nadezhda Meshcheriakova,Z. H. Kamolova
Cancer Urology. 2021; 16(4): 160
[Pubmed]  [Google Scholar] [DOI]
5 Impact of PET/CT for Assessing Response to Immunotherapy—A Clinical Perspective
David Lang,Gerald Wahl,Nikolaus Poier,Sebastian Graf,David Kiesl,Bernd Lamprecht,Michael Gabriel
Journal of Clinical Medicine. 2020; 9(11): 3483
[Pubmed]  [Google Scholar] [DOI]
6 Imaging for Metastatic Renal Cell Carcinoma
Soumya V.L. Vig,Elcin Zan,Stella K. Kang
Urologic Clinics of North America. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging
Winston B. Joe,Jessica G. Zarzour,Andrew J. Gunn
Radiology: Imaging Cancer. 2019; 1(2): e190002
[Pubmed]  [Google Scholar] [DOI]
8 Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma
Vidhya Karivedu,Amit L. Jain,Thomas J. Eluvathingal,Abhinav Sidana
Current Urology Reports. 2019; 20(10)
[Pubmed]  [Google Scholar] [DOI]
9 Thoracic Manifestations of Genitourinary Neoplasms and Treatment-related Complications
Justin T. Stowell,Sonia L. Betancourt-Cuellar,Brett W. Carter,Carol C. Wu,Christopher M. Walker
Journal of Thoracic Imaging. 2019; 34(3): W36
[Pubmed]  [Google Scholar] [DOI]
10 Molecular Imaging of Renal Malignancy: A Review
C. Elias Graybiel,Robert R. Flavell,Zhen J. Wang,Spencer C. Behr
Current Radiology Reports. 2019; 7(4)
[Pubmed]  [Google Scholar] [DOI]
11 Role of 18 F-FDG PET/CT in post-operative assessment and therapeutic follow up of renal cell carcinoma
Tamer W. Kassem,Nayef K. Ramadan,Sameh A.Z. Hanna
The Egyptian Journal of Radiology and Nuclear Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
12 Imaging tumour thrombus of clear cell renal cell carcinoma: FDG PET or PSMA PET? Direct in vivo comparison of two technologies
Seyedehpariya Saadat,Bibiana Tie,Simon Wood,Ian Vela,Handoo Rhee
Urology Case Reports. 2018; 16: 4
[Pubmed]  [Google Scholar] [DOI]
13 Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: A diagnostic imaging modality in renal cancer patients
Ekhlas Abdelmonem Ibrahem Nasr Shaban
The Egyptian Journal of Radiology and Nuclear Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
14 Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma
Huan Ma,Guohua Shen,Bin Liu,Yuanyou Yang,Pengwei Ren,Anren Kuang
Nuclear Medicine Communications. 2017; 38(2): 156
[Pubmed]  [Google Scholar] [DOI]
15 Advances in medical imaging for the diagnosis and management of common genitourinary cancers
Mohammad H. Bagheri,Mark A. Ahlman,Liza Lindenberg,Baris Turkbey,Jeffrey Lin,Ali Cahid Civelek,Ashkan A. Malayeri,Piyush K. Agarwal,Peter L. Choyke,Les R. Folio,Andrea B. Apolo
Urologic Oncology: Seminars and Original Investigations. 2017; 35(7): 473
[Pubmed]  [Google Scholar] [DOI]
16 Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence
Studies on Stem Cells Research and Therapy. 2017; 3(1): 001
[Pubmed]  [Google Scholar] [DOI]
17 Update on advances in molecular PET in urological oncology
Kazuhiro Kitajima,Shingo Yamamoto,Kazuhito Fukushima,Ryogo Minamimoto,Takao Kamai,Hossein Jadvar
Japanese Journal of Radiology. 2016;
[Pubmed]  [Google Scholar] [DOI]
18 The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations
Yiyan Liu
Frontiers in Oncology. 2016; 6
[Pubmed]  [Google Scholar] [DOI]


Read this article